Phase II feasibility study of adjuvant S-1 plus CPT-11 for stage III gastric cancer patients after curative D2 gastrectomy (OGSG 0801).

被引：0
|
作者：
Kimura, Yutaka
Fujitani, Kazumasa
Ueda, Shugo
Taniguchi, Hirokazu
Imamura, Hiroshi
Gofuku, Junji
Tamura, Shigeyuki
Kurokawa, Yukinori
Takiuchi, Hiroya
Furukawa, Hiroshi
机构：
[1] NTT West Osaka Hosp, Dept Surg, Osaka, Japan
[2] Osaka Natl Hosp, Osaka, Japan
[3] Kitano Hosp, Dept Surg, Osaka, Japan
[4] NTT West Osaka Hosp, Osaka, Japan
[5] Sakai Municipal Hosp, Sakai, Osaka, Japan
[6] Kaizuka Municipal Hosp, Dept Surg, Kaizuka, Japan
[7] Kansai Rosai Hosp, Amagasaki, Hyogo, Japan
[8] Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, Osaka, Japan
[9] Osaka Med Coll, Osaka, Japan
[10] Sakai Municipal Hosp, Dept Surg, Sakai, Osaka, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 04期
关键词：
D O I：
10.1200/jco.2012.30.4_suppl.142
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
142
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Risk factors for peritoneal recurrence in stage II/III gastric cancer patients who received S-1 adjuvant chemotherapy after D2 gastrectomy
    Aoyama, Toru
    Yoshikawa, Takaki
    Shirai, Junya
    Fujikawa, Hirohito
    Hayashi, Tsutomu
    Ogata, Takashi
    Cho, Haruhiko
    Yukawa, Norio
    Oshima, Takashi
    Rino, Yasushi
    Masuda, Munetaka
    Tsuburaya, Akira
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [22] Risk Factors for Peritoneal Recurrence in Stage II/III Gastric Cancer Patients Who Received S-1 Adjuvant Chemotherapy After D2 Gastrectomy
    Toru Aoyama
    Takaki Yoshikawa
    Tsutomu Hayashi
    Hiroshi Kuwabara
    Yo Mikayama
    Takashi Ogata
    Haruhiko Cho
    Akira Tsuburaya
    Annals of Surgical Oncology, 2012, 19 : 1568 - 1574
  • [23] Randomized phase II study of CPT-11 versus PTX versus each combination chemotherapy with S-1 for advanced gastric cancer that is refractory to S-1 or S-1 plus CDDP: OGSG0701
    Kawase, Tomono
    Imamura, Hiroshi
    Goto, Masahiro
    Kimura, Yutaka
    Ueda, Shugo
    Matsuyama, Jin
    Nishikawa, Kazuhiro
    Sugimoto, Naotoshi
    Fujita, Junya
    Tamura, Takao
    Fukushima, Norimasa
    Kawakami, Hisato
    Sakai, Daisuke
    Kurokawa, Yukinori
    Shimokawa, Toshio
    Satoh, Taroh
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (10) : 1871 - 1880
  • [24] Randomized phase II study of CPT-11 versus PTX versus each combination chemotherapy with S-1 for advanced gastric cancer that is refractory to S-1 or S-1 plus CDDP: OGSG0701
    Tomono Kawase
    Hiroshi Imamura
    Masahiro Goto
    Yutaka Kimura
    Shugo Ueda
    Jin Matsuyama
    Kazuhiro Nishikawa
    Naotoshi Sugimoto
    Junya Fujita
    Takao Tamura
    Norimasa Fukushima
    Hisato Kawakami
    Daisuke Sakai
    Yukinori Kurokawa
    Toshio Shimokawa
    Taroh Satoh
    International Journal of Clinical Oncology, 2021, 26 : 1871 - 1880
  • [25] Adjuvant capecitabine plus oxaliplatin after D2 gastrectomy in Japanese patients with gastric cancer: a phase II study
    Fuse, Nozomu
    Bando, Hideaki
    Chin, Keisho
    Ito, Seiji
    Yoshikawa, Takaki
    Tsuburaya, Akira
    Terashima, Masanori
    Kawashima, Yoshiyuki
    Fukunaga, Tetsu
    Gotoh, Masahiro
    Emi, Yasunori
    Yoshida, Kazuhiro
    Oki, Eiji
    Takahashi, Seiji
    Kuriki, Hiroshi
    Sato, Kumi
    Sasako, Mitsuru
    GASTRIC CANCER, 2017, 20 (02) : 332 - 340
  • [26] Adjuvant capecitabine plus oxaliplatin after D2 gastrectomy in Japanese patients with gastric cancer: a phase II study
    Nozomu Fuse
    Hideaki Bando
    Keisho Chin
    Seiji Ito
    Takaki Yoshikawa
    Akira Tsuburaya
    Masanori Terashima
    Yoshiyuki Kawashima
    Tetsu Fukunaga
    Masahiro Gotoh
    Yasunori Emi
    Kazuhiro Yoshida
    Eiji Oki
    Seiji Takahashi
    Hiroshi Kuriki
    Kumi Sato
    Mitsuru Sasako
    Gastric Cancer, 2017, 20 : 332 - 340
  • [27] Phase II trial of biweekly CPT-11 plus CDDP for patients with unresectable or recurrent gastric cancer refractory to S-1
    Rino, Y.
    Oshima, T.
    Yukawa, N.
    Yamada, R.
    Sato, T.
    Takahashi, M.
    Matsukawa, H.
    Yamamoto, Y.
    Shiraishi, R.
    Masuda, M.
    Imada, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [28] Phase II study of CPT-11 plus CDDP in patients with metastatic gastric cancer
    Narahara, H
    Imamura, H
    Ikeda, M
    Kobayashi, K
    Fujitani, K
    Kato, M
    Iwamoto, H
    Takabayashi, A
    Tsukuma, H
    Tsujinaka, T
    Furukawa, H
    Taguchi, T
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 438 - 438
  • [29] Phase I/II study of irinotecan (CPT-11) and S-1 in the treatment of advanced gastric cancer
    Katsube, Takao
    Ogawa, Kenji
    Ichikawa, Wataru
    Fujii, Masashi
    Tokunaga, Akira
    Takagi, Yuh
    Kochi, Misugu
    Hayashi, Kazuhiko
    Kubota, Tetsuro
    Aiba, Keisuke
    Arai, Kuniyoshi
    Terashima, Masanori
    Kitajima, Masaki
    ANTI-CANCER DRUGS, 2007, 18 (05) : 605 - 610
  • [30] A retrospective study of adjuvant albumin-bound paclitaxel plus S-1 after D2 gastrectomy versus oxaliplatin plus S-1 in gastric cancer
    Li, Ning
    Wu, Hui
    Xu, Xin
    Wei, Qinming
    Ding, Yongfeng
    Liu, Shan
    Wu, Jinqiong
    Zheng, Yulong
    Xu, Nong
    Gao, Yuan
    Jiang, Haiping
    SCIENTIFIC REPORTS, 2024, 14 (01):
12345